Home / Products / EQUIVAC® INNOVATOR EHV-1/4

Print page content Print
Increase text size Decrease text size
Text Size

EQUIVAC® INNOVATOR EHV-1/4

EQUIVAC® INNOVATOR EHV-1/4 is for the vaccination of healthy horses as an aid in the prevention of equine rhinopneumonitis due to types 1 and 4 viruses.

Collapse All
  • Key Benefits

    Protection against upper-respiratory disease should include vaccination for EHV-1 and EHV4.

  • Dosing and Administration

    Horses, inject one 1 mL dose intramuscularly using aseptic technique.

    Administer a second 1 mL dose 3 to 4 weeks after the first dose.

    A 1 mL booster dose should be given annually.


PRECAUTIONS: Store in the dark at 2° to 7°C (35° to 45°F). AVOID FREEZING. SHAKE WELL. Use entire contents when first opened. In some instances, transient local reactions may occur at the injection site. Do not vaccinate within 21 days before slaughter.

In case of anaphylactoid reaction, administer epinephrine.

Thimerosal, neomycin and polymyxin B added as preservatives.

For Veterinary Use Only

Shop Now!

CONTACT US

1-888-963-8471

Mon–Fri, 8:30am–6:30pm ET

zoetis logo United States flag United States

This site is intended for U.S. Animal Healthcare Professionals. The product information provided in this site is intended only for residents of the United States. The products discussed herein may not have marketing authorization or may have different product labeling in different countries. The animal health information contained herein is provided for educational purposes only and is not intended to replace discussions with an animal healthcare professional. All decisions regarding the care of a veterinary patient must be made with an animal healthcare professional, considering the unique characteristics of the patient.

All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted. ©2024 Zoetis Services LLC. All rights reserved.